(Q39330257)

11 September 2017

Withaferin A-related steroids from Withania aristata exhibit potent antiproliferative activity by inducing apoptosis in human tumor cells (English)

1 reference

17alpha-hydroxywithaferin A

11 September 2017

0 references

1 reference

1 reference

[(2R)-2-[(1S)-1-[(1S,2R,5S,6S,7R,9R,11S,12S,15R,16S)-5,6-dihydroxy-2,16-dimethyl-3-oxo-8-oxapentacyclo[9.7.0.02,7.07,9.012,16]octadecan-15-yl]ethyl]-4-methyl-6-oxo-2,3-dihydropyran-5-yl]methyl acetate

1 reference

27-O-Acetylwithaferin A

1 reference

(3aR,3bS,5aS,6R,8aS,8bS,10R,10aS)-10-hydroxy-6-[(1S)-1-[(2R)-5-(hydroxymethyl)-4-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-3a,5a-dimethyl-3-oxo-1,2,3b,4,5,6,7,8,8a,8b,9,10-dodecahydroindeno[6,7-e]indene-10a-carbaldehyde

1 reference

(2R)-5-(hydroxymethyl)-4-methyl-2-[(1S)-1-[(3S,4S,5R,6R,8S,9S,10R,13S,14S,17R)-3,4,5,6-tetrahydroxy-10,13-dimethyl-1-oxo-3,4,6,7,8,9,11,12,14,15,16,17-dodecahydro-2H-cyclopenta[a]phenanthren-17-yl]ethyl]-2,3-dihydropyran-6-one

1 reference

(1S,2R,6S,7R,9R,11S,12S,15R,16S)-6-hydroxy-15-[(1S)-1-[(2S)-5-(hydroxymethyl)-4-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-2,16-dimethyl-8-oxapentacyclo[9.7.0.02,7.07,9.012,16]octadec-4-en-3-one

1 reference

1 reference

(22R)-4beta-Hydroxy-5beta,6beta:22,26-diepoxyergosta-2,16,24-triene-1,26-dione

1 reference

(1S,2R,6S,7R,9R,11S,12S,14S,15Z,16S)-6,14-dihydroxy-15-[1-[(2R)-5-(hydroxymethyl)-4-methyl-6-oxo-2,3-dihydropyran-2-yl]ethylidene]-2,16-dimethyl-8-oxapentacyclo[9.7.0.02,7.07,9.012,16]octadec-4-en-3-one

1 reference

6alpha-Chloro-5beta-hydroxywithaferin A

1 reference

(3aR,3bS,5aS,6R,8aS,8bS,10R,10aS)-6-[(1S)-1-[(2R)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-10-hydroxy-3a,5a-dimethyl-3-oxo-1,2,3b,4,5,6,7,8,8a,8b,9,10-dodecahydroindeno[6,7-e]indene-10a-carbaldehyde

1 reference

(22R)-5,6beta-Epoxy-4beta,22-dihydroxy-1-oxo-5beta-ergosta-2,14,24-trien-26-oic acid delta-lactone

1 reference

1 reference

2-[[(2R)-2-[(1S)-1-[(1S,2R,6S,7R,9R,11S,12S,15R,16S)-6-hydroxy-2,16-dimethyl-3-oxo-8-oxapentacyclo[9.7.0.02,7.07,9.012,16]octadec-4-en-15-yl]ethyl]-4-methyl-6-oxo-2,3-dihydropyran-5-yl]methoxy]propan-2-yl formate

1 reference

2,3-dihydrowithaferin A

1 reference

(3aR,3bS,5aS,6R,8aS,8bS,10R,10aS)-10-hydroxy-6-[(1S)-1-[(2R)-5-(hydroxymethyl)-4-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-3a,5a-dimethyl-3-oxo-3b,4,5,6,7,8,8a,8b,9,10-decahydroindeno[6,7-e]indene-10a-carbaldehyde

1 reference

27-O-(tert-Butyldimethylsilyl)withaferin A

1 reference

2,3-Didehydrosomnifericin

1 reference

4-oxo-27-TBDMS Withaferin A

4-Dehydrowithaferin A

1 reference

1 reference

1 reference

Gabriel G Llanos

1

1 reference

11 September 2017

Liliana M Araujo

2

1 reference

11 September 2017

Ignacio A Jiménez

3

1 reference

11 September 2017

Laila M Moujir

4

1 reference

11 September 2017

Isabel L Bazzocchi

5

1 reference

11 September 2017

1 June 2012

1 reference

European Journal of Medicinal Chemistry

11 September 2017

1 reference

11 September 2017

54

1 reference

11 September 2017

499-511

1 reference

Viscosalactone A and Viscosalactone B, Two New Steroidal Lactones from Physalis viscosa

11 September 2017

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.3987/S-1981-01-0317

Cholinesterase inhibiting withanolides from Withania somnifera

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.52.1358

Par-4-dependent apoptosis by the dietary compound withaferin A in prostate cancer cells

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1158/0008-5472.CAN-06-2430

Identifiers

DOI

10.1016/J.EJMECH.2012.05.032

1 reference

11 September 2017

1 reference